Gabriel Leung's Insider Trades & SAST Disclosures
Gabriel Leung's most recent trade in NovoCure Ltd was a trade of 6,229 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gabriel Leung.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 83,192 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 04 Jun 2024 | 964 | 78,175 (0%) | 0% | 23.9 | 23,025 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 79,139 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,350 | 4,350 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 2,427 | 75,286 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 152.50 per share. | 05 Aug 2021 | 1,000 | 72,859 (0%) | 0% | 152.5 | 152,500 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 1,000 | 2,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 05 Aug 2021 | 1,000 | 73,859 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 1,000 | 3,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 06 Jul 2021 | 1,000 | 73,859 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 183.54 per share. | 06 Jul 2021 | 1,000 | 72,859 (0%) | 0% | 183.5 | 183,540 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,499 | 1,499 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 814 | 72,859 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 204.55 per share. | 07 Jun 2021 | 1,000 | 72,045 (0%) | 0% | 204.6 | 204,550 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 1,000 | 4,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 07 Jun 2021 | 1,000 | 73,045 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 05 May 2021 | 1,000 | 73,045 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 1,000 | 5,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 199.67 per share. | 05 May 2021 | 1,000 | 72,045 (0%) | 0% | 199.7 | 199,670 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 6,000 | 6,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 13 Apr 2021 | 6,000 | 78,045 (0%) | 0% | 31.5 | 188,700 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 198.01 per share. | 13 Apr 2021 | 3,500 | 74,545 (0%) | 0% | 198.0 | 693,035 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Apr 2021 | 2,500 | 72,045 (0%) | 0% | 200 | 500,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 2,173 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 10,000 | 82,045 (0%) | 0% | 7.5 | 74,800 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 14 Sep 2020 | 10,000 | 72,045 (0%) | 0% | 95 | 950,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 7,392 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Sep 2020 | 7,392 | 72,045 (0%) | 0% | 100 | 739,200 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 7,392 | 79,437 (0%) | 0% | 7.5 | 55,292 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 2,173 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Sep 2020 | 2,173 | 72,045 (0%) | 0% | 100 | 217,300 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 2,173 | 74,218 (0%) | 0% | 7.5 | 16,254 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 09 Sep 2020 | 10,000 | 82,045 (0%) | 0% | 7.5 | 74,800 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 10,000 | 12,173 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 09 Sep 2020 | 10,000 | 72,045 (0%) | 0% | 90 | 900,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 09 Sep 2020 | 9,114 | 81,159 (0%) | 0% | 7.0 | 64,071 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 9,114 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 85.39 per share. | 09 Sep 2020 | 9,014 | 72,145 (0%) | 0% | 85.4 | 769,687 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 86.06 per share. | 09 Sep 2020 | 100 | 72,045 (0%) | 0% | 86.1 | 8,606 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2020 | 100 | 9,114 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 02 Sep 2020 | 100 | 72,145 (0%) | 0% | 7.0 | 703 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 02 Sep 2020 | 100 | 72,045 (0%) | 0% | 85 | 8,500 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2020 | 7,112 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 80.13 per share. | 25 Aug 2020 | 7,112 | 72,045 (0%) | 0% | 80.1 | 569,892 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 25 Aug 2020 | 7,112 | 79,157 (0%) | 0% | 7.0 | 49,997 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2020 | 7,112 | 7,112 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 30 Jul 2020 | 7,112 | 72,045 (0%) | 0% | 75 | 533,400 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 30 Jul 2020 | 7,112 | 79,157 (0%) | 0% | 7.0 | 49,997 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2020 | 9,500 | 9,214 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 21 Jul 2020 | 9,500 | 81,545 (0%) | 0% | 7.0 | 66,785 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 66.75 per share. | 21 Jul 2020 | 4,573 | 76,549 (0%) | 0% | 66.8 | 305,257 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 67.46 per share. | 21 Jul 2020 | 4,504 | 72,045 (0%) | 0% | 67.5 | 303,844 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2020 | 500 | 18,714 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 65.07 per share. | 21 Jul 2020 | 500 | 72,045 (0%) | 0% | 65.1 | 32,537 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 21 Jul 2020 | 500 | 72,545 (0%) | 0% | 7.0 | 3,515 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 65.48 per share. | 21 Jul 2020 | 423 | 81,122 (0%) | 0% | 65.5 | 27,696 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 5,101 | 5,101 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 2,541 | 72,045 | - | 0 | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges